SimBioSys®, a clinical AI company pioneering the use of spatial biophysics to advance precision in breast cancer treatment, has entered into a strategic, non-exclusive...
Ricoh USA, Inc. and SimBioSys, Inc., announced a collaborative initiative to explore cutting-edge technologies with the potential to aid the treatment of breast cancer....
TumorSight Plan is the first clinical decision support tool to support more effective provider-patient decision making and individualize surgical planning to right-size care.
SimBioSys®, a...
PhenoScope can cut drug development time and costs significantly, while delivering safer & more effective therapy for cancer patients
SimBioSys, a leading innovator in precision...
SimBioSys, a TechBio company unlocking the power of spatial biophysics with artificial intelligence (AI) and biophysical modeling to redefine precision medicine for cancer, announced...